In adults with CKM syndrome, finerenone vs. placebo reduced sudden death at a median 2.9 y. (acpjournals.org)

Authors: Joshi M … Kelsey M Journal: Annals of Internal Medicine Published: 2026-09-01 DOI: https://doi.org/10.7326/ANNALS-26-03105-JC